Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01521338 · ClinicalTrials.gov registry record
G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)
A clinical trial of Cystic Fibrosis, sponsored by Steven M Rowe.
- Completed
- Registry status
- 120
- Enrollment target
- 20
- Study locations
NCT01521338: Completed study of Cystic Fibrosis, sponsored by Steven M Rowe.
NCT01521338 is a study of Cystic Fibrosis that has completed, run by Steven M Rowe. The registered enrollment target is 120 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (33% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01521338, a study of Cystic Fibrosis, has completed, sponsored by Steven M Rowe.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this research study is to collect blood and urine samples from people who have either the R117H type of CF or the non-G551D gating type of CF to be kept for future research.We will also use some of the collected blood to measure the number of neutrophils.
Primary Outcome
Change in FEV1% predicted between Visit 1 and visit 5
Conditions Studied
Study Locations (20)
Michigan
- University of Michigan - Ann Arbor
- Children's Hospital of Michigan - Detroit
- Grand Rapids CF Center - Grand Rapids
Colorado
- The Children's Hospital Colarado - Aurora
- National Jewish Health - Denver
Indiana
- Riley Hospital for Children Indiana University Medical Center - Indianapolis
- Indianapolis University - Indianapolis
Massachusetts
- Massachusetts General Hospital - Boston
- Children's Hospital Boston - Boston
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Phoenix Childrens Hospital - Phoenix
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
California
- Stanford University Medical Center - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-01 |
| Est. Completion | 2021-06 |
What the finished NCT01521338 record still lists
NCT01521338 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 0 interventions.
NCT01521338 names 20 study sites across 15 states, led by Michigan, Colorado, Indiana.
Frequently Asked Questions
What is clinical trial NCT01521338 about?
NCT01521338 is a clinical study titled "G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)". The goal of this research study is to collect blood and urine samples from people who have either the R117H type of CF or the non-G551D gating type of CF to be kept for future research.We will also use some of the collected blood to measure the number of neutrophils.
What is the current status of trial NCT01521338?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-01. Estimated completion is 2021-06.
What conditions does trial NCT01521338 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
Who is sponsoring clinical trial NCT01521338?
This trial is sponsored by Steven M Rowe, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01521338 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01521338's enrollment target sits among peer trials
120 54th of 169 higher than 116 of 169 other Cystic Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cystic Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RECRUITING
-
Assessing Tenapanor as a Treatment of CF-related Constipation.
RECRUITING · Phase 3
-
Genetics of Insulin and Incretins in Cystic Fibrosis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia